N,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

Catalog No. :
ACUTRF573
CAS No. :
1046862-09-2
Molecular Formula :
C14H23BN2O2
Molecular Weight :
262.16

IUPAC Name:N,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine

N,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1115.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
IUPAC NameN,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
Molecular FormulaC14H23BN2O2
Molecular Weight262.16
SMILESCC1(C)C(C)(C)OB(C2=CN=C(N(C)C)C=C2C)O1
InChI KeyYSXJGDNKTHWFMZ-UHFFFAOYSA-N
Synonym6-Dimethylamino-4-methylpyridine-3-boronic acid pinacol ester;N,N,4-triMethyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-aMine;N,N,4-TRIMETHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-PYRIDINAMINE;2-(Dimethylamino)-4-methylpyridine-5-boronic acid pinacol ester;2-Pyridinamine, N,N,4-trimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1046862-09-2

Synthetic Route by SureRoute

1. ACUTRF573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUTRF573 route product structure diagram
    ACUTRF5731046862-09-2
Inquiry

2. ACUTRF573 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQPLT257 route compound structure diagram
    ACQPLT2571382851-54-8 In Stock
  4. Then
  5. ACUTRF573 route product structure diagram
    ACUTRF5731046862-09-2
Inquiry

Comments (0)